Kobe, Japan

Miyuki Nishimura


 


Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 334(Granted Patents)


Location History:

  • Kyoto, JP (2006 - 2010)
  • Okaya, JP (2011 - 2013)
  • Hyogo, JP (2013 - 2015)
  • Kobe, JP (2013 - 2017)

Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Miyuki Nishimura

Introduction

Miyuki Nishimura is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 13 patents to her name, her work has the potential to impact the treatment of various inflammatory and autoimmune disorders, as well as cancer.

Latest Patents

Among her latest patents is the invention of neutralizing anti-CCL20 antibodies. This invention relates to novel humanized, chimeric, and murine antibodies that specifically bind to the human CC chemokine ligand 20 (CCL20). The patent also covers heavy chains and light chains of these antibodies, as well as isolated nucleic acids, recombinant vectors, and host cells that encode these chains. The anti-CCL20 antibodies can be utilized in therapeutic applications for treating inflammatory and autoimmune disorders, as well as cancer. Another significant patent is for anti-human XCR1 antibodies, which provides a monoclonal antibody that binds to human XCR1. This antibody targets specific epitopes within the amino acid sequence, showcasing her innovative approach to antibody development.

Career Highlights

Miyuki Nishimura has worked with notable companies, including Eisai R&D Management Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the field of biotechnology.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Toshio Imai and Tetsu Kawano. These partnerships have further enhanced her research and development efforts, leading to significant advancements in her field.

Conclusion

Miyuki Nishimura's innovative work in the development of therapeutic antibodies has positioned her as a key figure in biotechnology. Her patents reflect her dedication to addressing critical health challenges, and her collaborations have strengthened her contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…